Logo image of USPH

U.S. PHYSICAL THERAPY INC (USPH) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:USPH - US90337L1089 - Common Stock

73.85 USD
-0.09 (-0.12%)
Last: 11/28/2025, 8:04:45 PM
73.85 USD
0 (0%)
After Hours: 11/28/2025, 8:04:45 PM
Fundamental Rating

5

Taking everything into account, USPH scores 5 out of 10 in our fundamental rating. USPH was compared to 101 industry peers in the Health Care Providers & Services industry. USPH has an average financial health and profitability rating. USPH has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

USPH had positive earnings in the past year.
USPH had a positive operating cash flow in the past year.
In the past 5 years USPH has always been profitable.
USPH had a positive operating cash flow in each of the past 5 years.
USPH Yearly Net Income VS EBIT VS OCF VS FCFUSPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

USPH has a Return On Assets of 3.01%. This is in the better half of the industry: USPH outperforms 65.35% of its industry peers.
USPH has a Return On Equity of 7.15%. This is in the better half of the industry: USPH outperforms 68.32% of its industry peers.
The Return On Invested Capital of USPH (6.11%) is better than 63.37% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for USPH is below the industry average of 9.26%.
The 3 year average ROIC (5.78%) for USPH is below the current ROIC(6.11%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.01%
ROE 7.15%
ROIC 6.11%
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
USPH Yearly ROA, ROE, ROICUSPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a decent Profit Margin value of 4.75%, USPH is doing good in the industry, outperforming 78.22% of the companies in the same industry.
USPH's Profit Margin has declined in the last couple of years.
USPH has a Operating Margin of 11.52%. This is amongst the best in the industry. USPH outperforms 80.20% of its industry peers.
USPH's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 18.80%, USPH is not doing good in the industry: 63.37% of the companies in the same industry are doing better.
USPH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 11.52%
PM (TTM) 4.75%
GM 18.8%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
USPH Yearly Profit, Operating, Gross MarginsUSPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), USPH is destroying value.
USPH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, USPH has more shares outstanding
Compared to 1 year ago, USPH has an improved debt to assets ratio.
USPH Yearly Shares OutstandingUSPH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
USPH Yearly Total Debt VS Total AssetsUSPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

USPH has an Altman-Z score of 2.15. This is not the best score and indicates that USPH is in the grey zone with still only limited risk for bankruptcy at the moment.
USPH has a Altman-Z score of 2.15. This is comparable to the rest of the industry: USPH outperforms 48.51% of its industry peers.
USPH has a debt to FCF ratio of 2.82. This is a good value and a sign of high solvency as USPH would need 2.82 years to pay back of all of its debts.
USPH has a better Debt to FCF ratio (2.82) than 77.23% of its industry peers.
USPH has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.30, USPH is doing good in the industry, outperforming 67.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.82
Altman-Z 2.15
ROIC/WACC0.71
WACC8.63%
USPH Yearly LT Debt VS Equity VS FCFUSPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

USPH has a Current Ratio of 1.20. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
USPH has a Current ratio (1.20) which is in line with its industry peers.
USPH has a Quick Ratio of 1.20. This is a normal value and indicates that USPH is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of USPH (1.20) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.2
USPH Yearly Current Assets VS Current LiabilitesUSPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 3.17% over the past year.
The Earnings Per Share has been decreasing by -1.76% on average over the past years.
The Revenue has grown by 17.50% in the past year. This is quite good.
USPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.85% yearly.
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%

3.2 Future

The Earnings Per Share is expected to grow by 9.98% on average over the next years. This is quite good.
Based on estimates for the next years, USPH will show a quite strong growth in Revenue. The Revenue will grow by 9.97% on average per year.
EPS Next Y9.38%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
EPS Next 5YN/A
Revenue Next Year16.19%
Revenue Next 2Y11.04%
Revenue Next 3Y9.97%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
USPH Yearly Revenue VS EstimatesUSPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
USPH Yearly EPS VS EstimatesUSPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 28.40, USPH can be considered very expensive at the moment.
USPH's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.31. USPH is around the same levels.
A Price/Forward Earnings ratio of 23.67 indicates a rather expensive valuation of USPH.
USPH's Price/Forward Earnings is on the same level as the industry average.
USPH is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 36.59, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.4
Fwd PE 23.67
USPH Price Earnings VS Forward Price EarningsUSPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, USPH is valued a bit cheaper than the industry average as 68.32% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of USPH indicates a somewhat cheap valuation: USPH is cheaper than 66.34% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 19.73
EV/EBITDA 11.29
USPH Per share dataUSPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
USPH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.03
PEG (5Y)N/A
EPS Next 2Y9.96%
EPS Next 3Y9.98%

5

5. Dividend

5.1 Amount

USPH has a Yearly Dividend Yield of 2.43%.
Compared to an average industry Dividend Yield of 2.48, USPH pays a better dividend. On top of this USPH pays more dividend than 94.06% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, USPH has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.43%

5.2 History

On average, the dividend of USPH grows each year by 9.09%, which is quite nice.
USPH has paid a dividend for at least 10 years, which is a reliable track record.
USPH has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.09%
Div Incr Years4
Div Non Decr Years4
USPH Yearly Dividends per shareUSPH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

75.41% of the earnings are spent on dividend by USPH. This is not a sustainable payout ratio.
The dividend of USPH is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP75.41%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
USPH Yearly Income VS Free CF VS DividendUSPH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
USPH Dividend Payout.USPH Dividend Payout, showing the Payout Ratio.USPH Dividend Payout.PayoutRetained Earnings

U.S. PHYSICAL THERAPY INC

NYSE:USPH (11/28/2025, 8:04:45 PM)

After market: 73.85 0 (0%)

73.85

-0.09 (-0.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners105.82%
Inst Owner Change5.17%
Ins Owners1.84%
Ins Owner Change-1.14%
Market Cap1.12B
Revenue(TTM)758.71M
Net Income(TTM)36.02M
Analysts84.62
Price Target108.32 (46.68%)
Short Float %5.28%
Short Ratio4.97
Dividend
Industry RankSector Rank
Dividend Yield 2.43%
Yearly Dividend1.76
Dividend Growth(5Y)9.09%
DP75.41%
Div Incr Years4
Div Non Decr Years4
Ex-Date11-17 2025-11-17 (0.45)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.82%
Min EPS beat(2)-3.42%
Max EPS beat(2)11.07%
EPS beat(4)2
Avg EPS beat(4)2.36%
Min EPS beat(4)-7.64%
Max EPS beat(4)11.07%
EPS beat(8)3
Avg EPS beat(8)-1.56%
EPS beat(12)4
Avg EPS beat(12)-0.7%
EPS beat(16)7
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)0.84%
Min Revenue beat(2)-0.36%
Max Revenue beat(2)2.04%
Revenue beat(4)3
Avg Revenue beat(4)1.14%
Min Revenue beat(4)-0.36%
Max Revenue beat(4)2.04%
Revenue beat(8)6
Avg Revenue beat(8)0.78%
Revenue beat(12)7
Avg Revenue beat(12)0.4%
Revenue beat(16)8
Avg Revenue beat(16)-0.02%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-3.88%
EPS NQ rev (3m)-3.88%
EPS NY rev (1m)0%
EPS NY rev (3m)5.2%
Revenue NQ rev (1m)1.41%
Revenue NQ rev (3m)1.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE 28.4
Fwd PE 23.67
P/S 1.48
P/FCF 19.73
P/OCF 16.14
P/B 2.23
P/tB N/A
EV/EBITDA 11.29
EPS(TTM)2.6
EY3.52%
EPS(NY)3.12
Fwd EY4.22%
FCF(TTM)3.74
FCFY5.07%
OCF(TTM)4.57
OCFY6.19%
SpS49.92
BVpS33.13
TBVpS-23.9
PEG (NY)3.03
PEG (5Y)N/A
Graham Number44.02
Profitability
Industry RankSector Rank
ROA 3.01%
ROE 7.15%
ROCE 8.08%
ROIC 6.11%
ROICexc 6.29%
ROICexgc 36.03%
OM 11.52%
PM (TTM) 4.75%
GM 18.8%
FCFM 7.5%
ROA(3y)2.54%
ROA(5y)3.42%
ROE(3y)6.25%
ROE(5y)8.16%
ROIC(3y)5.78%
ROIC(5y)6.77%
ROICexc(3y)6.35%
ROICexc(5y)7.3%
ROICexgc(3y)37.05%
ROICexgc(5y)44.29%
ROCE(3y)7.65%
ROCE(5y)8.96%
ROICexgc growth 3Y-11.04%
ROICexgc growth 5Y-7.52%
ROICexc growth 3Y-14.51%
ROICexc growth 5Y-13.29%
OM growth 3Y-9.96%
OM growth 5Y-5.7%
PM growth 3Y-13.05%
PM growth 5Y-8.65%
GM growth 3Y-6.9%
GM growth 5Y-3.92%
F-Score6
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 2.82
Debt/EBITDA 1.37
Cap/Depr 53.9%
Cap/Sales 1.67%
Interest Coverage 9.84
Cash Conversion 62.74%
Profit Quality 157.98%
Current Ratio 1.2
Quick Ratio 1.2
Altman-Z 2.15
F-Score6
WACC8.63%
ROIC/WACC0.71
Cap/Depr(3y)54.79%
Cap/Depr(5y)61.53%
Cap/Sales(3y)1.47%
Cap/Sales(5y)1.57%
Profit Quality(3y)269.82%
Profit Quality(5y)263.85%
High Growth Momentum
Growth
EPS 1Y (TTM)3.17%
EPS 3Y-6.63%
EPS 5Y-1.76%
EPS Q2Q%-4.35%
EPS Next Y9.38%
EPS Next 2Y9.96%
EPS Next 3Y9.98%
EPS Next 5YN/A
Revenue 1Y (TTM)17.5%
Revenue growth 3Y10.69%
Revenue growth 5Y6.85%
Sales Q2Q%17.32%
Revenue Next Year16.19%
Revenue Next 2Y11.04%
Revenue Next 3Y9.97%
Revenue Next 5YN/A
EBIT growth 1Y26.14%
EBIT growth 3Y-0.34%
EBIT growth 5Y0.76%
EBIT Next Year40.12%
EBIT Next 3Y18.72%
EBIT Next 5YN/A
FCF growth 1Y-11.66%
FCF growth 3Y-1.21%
FCF growth 5Y4.7%
OCF growth 1Y-4.01%
OCF growth 3Y-0.65%
OCF growth 5Y3.71%

U.S. PHYSICAL THERAPY INC / USPH FAQ

What is the ChartMill fundamental rating of U.S. PHYSICAL THERAPY INC (USPH) stock?

ChartMill assigns a fundamental rating of 5 / 10 to USPH.


Can you provide the valuation status for U.S. PHYSICAL THERAPY INC?

ChartMill assigns a valuation rating of 4 / 10 to U.S. PHYSICAL THERAPY INC (USPH). This can be considered as Fairly Valued.


What is the profitability of USPH stock?

U.S. PHYSICAL THERAPY INC (USPH) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for USPH stock?

The Earnings per Share (EPS) of U.S. PHYSICAL THERAPY INC (USPH) is expected to grow by 9.38% in the next year.


Can you provide the dividend sustainability for USPH stock?

The dividend rating of U.S. PHYSICAL THERAPY INC (USPH) is 5 / 10 and the dividend payout ratio is 75.41%.